- Joined
- Feb 16, 2009
- Messages
- 202
- Reaction score
- 2
I like the point you make and I'm not sure why I confused the two points.
I think I was just itching to talk about Kathryn Montgomery's book. I'm really digging it. I encourage everyone to check it out.
But Lokhtar, isn't a case report published in a peer reviewed journal by a physician antecdotal by definition? Would you discount these when considering treatment? If the treatment poses no harm, but antecdotally can produce benefit, what's the harm in utilizing it? I mean you have to admit cranial isn't on the top of the list in importance for studies to be conducted, so why not take the case reports seriously? After all, it's not like a UFO sighting, it's a professional documenting and submitting for peer review.
What's your take?
sweet jesus, how many logical fallacies can you put in one post? first point, there is harm done. You may attribute any positive responses to treatment as validation for future use of the treatment. So while no harm may be done to the first patients, harm is done on future patients. Second, case reports in the absence of true trial data does not mean that case reports are a more valid set of data.